Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
HK inno.N Eyes 2025 Korea Opportunity With mAbxience Denosumab Deal
Amgen’s Prolia/Xgeva Original Sales Close To $100m, mAbxience In Phase III
Jan 31 2023
•
By
Dean Rudge
HK inno.N plans to seek approval "quickly" • Source: Alamy
More from Biosimilars
More from Products
